LumiThera Acquires MacuLogix Assets (AdaptDx Pro)

Alcon to Acquire LumiThera

July 7, 2025

Medical Devices

Alcon, a leader in eye care, plans to acquire LumiThera, which develops light-based therapies for ophthalmology, including its photobiomodulation (PBM) device for treating early and intermediate dry age-related macular degeneration (AMD). The acquisition is expected to close in the third quarter of 2025, subject to customary closing conditions and a LumiThera shareholder vote.

LumiThera Acquires Diopsys

November 11, 2021

Medical Devices

LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.

Somatus Acquires Strategic Assets from Lumiata

April 28, 2022

Healthcare Services

Somatus has acquired strategic assets from Lumiata to integrate Lumiata's healthcare AI and predictive analytics into Somatus' RenalIQ platform, improving early identification of people with chronic kidney disease and prediction of disease progression. The deal brings Lumiata talent (including Jessica McCarthy) into Somatus and aims to strengthen care delivery, reduce costs for provider and health-plan partners, and address health inequities.

DiscernDx Acquires Luminist Labs

April 29, 2020

Biotechnology

DiscernDx, a Palo Alto precision medicine company, has acquired Luminist Labs, a privately-held diagnostic platform developer focused on early detection and diagnosis of liver disease. The acquisition will integrate Luminist's data and platform into DiscernDx's multi-omics system to accelerate development of non-invasive diagnostic and prognostic solutions for NASH and other chronic metabolic liver diseases. Terms were not disclosed.

AdaptHealth Acquires Solara Medical Supplies from Linden Capital Partners

May 26, 2020

Healthcare Services

AdaptHealth Corp. has agreed to acquire Solara Medical Supplies, LLC from Linden Capital Partners, adding the largest independent U.S. distributor of continuous glucose monitors and other diabetes supplies to AdaptHealth's in-home medical supplies platform. The transaction is being funded with a combination of debt and equity commitments (including investments from One Equity Partners and Deerfield Management) and will see Solara's CEO Steve Foreman join AdaptHealth's leadership team.

Roche to Acquire LumiraDx Point-of-Care Technology Platform for $295 Million

January 2, 2024

Healthcare Services

LumiraDx has entered into a definitive agreement for Roche to acquire certain companies and related assets within LumiraDx’s point-of-care diagnostics platform business. Roche will pay $295 million at closing, with an additional payment of up to $55 million for reimbursement to fund the platform business until closing.